325 related articles for article (PubMed ID: 38534695)
1. Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria.
Zhang S; Liao X; Ding T; Ahn J
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534695
[TBL] [Abstract][Full Text] [Related]
2. β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward.
Narendrakumar L; Chakraborty M; Kumari S; Paul D; Das B
Front Microbiol; 2022; 13():1092556. PubMed ID: 36970185
[TBL] [Abstract][Full Text] [Related]
3. PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability.
Montaner M; Lopez-Argüello S; Oliver A; Moya B
Microbiol Spectr; 2023 Feb; 11(1):e0303822. PubMed ID: 36475840
[TBL] [Abstract][Full Text] [Related]
4. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Gehlot P; P H
Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
[TBL] [Abstract][Full Text] [Related]
5. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
6.
Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963
[TBL] [Abstract][Full Text] [Related]
7. Three decades of beta-lactamase inhibitors.
Drawz SM; Bonomo RA
Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
9. β-Lactams and β-Lactamase Inhibitors: An Overview.
Bush K; Bradford PA
Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27329032
[TBL] [Abstract][Full Text] [Related]
10. Penicillin-Binding Proteins, β-Lactamases, and β-Lactamase Inhibitors in β-Lactam-Producing Actinobacteria: Self-Resistance Mechanisms.
Martin JF; Alvarez-Alvarez R; Liras P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628478
[TBL] [Abstract][Full Text] [Related]
11. An Extensive Review on β-lactamase Enzymes and their Inhibitors.
Agarwal V; Tiwari A; Varadwaj P
Curr Med Chem; 2023; 30(7):783-808. PubMed ID: 35726414
[TBL] [Abstract][Full Text] [Related]
12. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
Bush K
Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase inhibitors: the story so far.
Pérez-Llarena FJ; Bou G
Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the development of β-lactamase inhibitors.
Jalde SS; Choi HK
J Microbiol; 2020 Aug; 58(8):633-647. PubMed ID: 32720096
[TBL] [Abstract][Full Text] [Related]
15. The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli.
Roach EJ; Uehara T; Daigle DM; Six DA; Khursigara CM
Microbiol Spectr; 2021 Oct; 9(2):e0091821. PubMed ID: 34494877
[TBL] [Abstract][Full Text] [Related]
16. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
17. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
Jones RN
Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.
Rajer F; Allander L; Karlsson PA; Sandegren L
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0029022. PubMed ID: 35652643
[TBL] [Abstract][Full Text] [Related]
19. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
